{"id":"https://openalex.org/W2731684792","doi":"https://doi.org/10.1016/j.eurpsy.2017.01.1758","title":"New designer benzodiazepines use in Barcelona","display_name":"New designer benzodiazepines use in Barcelona","publication_year":2017,"publication_date":"2017-04-01","ids":{"openalex":"https://openalex.org/W2731684792","doi":"https://doi.org/10.1016/j.eurpsy.2017.01.1758","mag":"2731684792"},"language":"en","primary_location":{"id":"doi:10.1016/j.eurpsy.2017.01.1758","doi":"https://doi.org/10.1016/j.eurpsy.2017.01.1758","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eurpsy.2017.01.1758","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/AC8744AB96132270DD6FFDB178CD79F3/S0924933800219329a.pdf/div-class-title-new-designer-benzodiazepines-use-in-barcelona-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/AC8744AB96132270DD6FFDB178CD79F3/S0924933800219329a.pdf/div-class-title-new-designer-benzodiazepines-use-in-barcelona-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111622595","display_name":"S. P\u00e9rez Gonz\u00e1lez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"S. P\u00e9rez Gonz\u00e1lez","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions , Parc","Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions , Parc","institution_ids":[]},{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047133012","display_name":"M. De Dios","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. De Dios Felis","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053921023","display_name":"Eila Monteagudo-Gimeno","orcid":"https://orcid.org/0000-0002-8301-9406","observed_orcids":["https://orcid.org/0000-0002-8301-9406"]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E. Monteagudo Gimeno","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035640817","display_name":"David Sanagust\u00edn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"D. Sanagust\u00edn Bosqued","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068374657","display_name":"Amira Trabsa","orcid":"https://orcid.org/0000-0002-8669-0676","observed_orcids":["https://orcid.org/0000-0002-8669-0676"]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Trabsa Biskri","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057322047","display_name":"Marc Grifell","orcid":"https://orcid.org/0000-0001-9815-5761","observed_orcids":["https://orcid.org/0000-0001-9815-5761"]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. Grifell Gu\u00e0rdia","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045572483","display_name":"Liliana Galindo","orcid":"https://orcid.org/0000-0002-2396-4772","observed_orcids":["https://orcid.org/0000-0002-2396-4772"]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"L. Galindo Guar\u00edn","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066780540","display_name":"P. Quintana Mathe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"P. Quintana Mathe","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036831245","display_name":"Marta Torrens","orcid":"https://orcid.org/0000-0001-6222-4761","observed_orcids":["https://orcid.org/0000-0001-6222-4761"]},"institutions":[{"id":"https://openalex.org/I4210133106","display_name":"Parc de Salut","ror":"https://ror.org/032exky44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210133106"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. Torrens Melich","raw_affiliation_strings":["Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Psychiatry, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133106"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210133106"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.03428177,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"41","issue":"S1","first_page":"S874","last_page":"S874"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenazepam","display_name":"phenazepam","score":0.8339999914169312},{"id":"https://openalex.org/keywords/etizolam","display_name":"etizolam","score":0.9959999918937683},{"id":"https://openalex.org/keywords/recreational-drug-use","display_name":"recreational drug use","score":0.9290000200271606},{"id":"https://openalex.org/keywords/harm-reduction","display_name":"harm reduction","score":0.5450000166893005},{"id":"https://openalex.org/keywords/drug-abuse-trends","display_name":"drug abuse trends","score":0.5370000004768372},{"id":"https://openalex.org/keywords/barcelona","display_name":"Barcelona","score":0.43799999356269836},{"id":"https://openalex.org/keywords/online-drug-sales","display_name":"online drug sales","score":0.4560000002384186},{"id":"https://openalex.org/keywords/benzodiazepine-dependence","display_name":"benzodiazepine dependence","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C529928208","wikidata":"https://www.wikidata.org/wiki/Q1458711","display_name":"Harm reduction","level":3,"score":0.6083393692970276},{"id":"https://openalex.org/C138147947","wikidata":"https://www.wikidata.org/wiki/Q1183659","display_name":"Declaration","level":2,"score":0.5268890857696533},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4416266679763794},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40001511573791504},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3277563452720642},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.27325212955474854},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.19316253066062927},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.eurpsy.2017.01.1758","doi":"https://doi.org/10.1016/j.eurpsy.2017.01.1758","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eurpsy.2017.01.1758","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/AC8744AB96132270DD6FFDB178CD79F3/S0924933800219329a.pdf/div-class-title-new-designer-benzodiazepines-use-in-barcelona-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.eurpsy.2017.01.1758","doi":"https://doi.org/10.1016/j.eurpsy.2017.01.1758","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eurpsy.2017.01.1758","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/AC8744AB96132270DD6FFDB178CD79F3/S0924933800219329a.pdf/div-class-title-new-designer-benzodiazepines-use-in-barcelona-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7400000095367432,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2731684792.pdf","grobid_xml":"https://content.openalex.org/works/W2731684792.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725"],"abstract_inverted_index":{"Introduction":[0],"New":[1],"designer":[2,45,153],"benzodiazepines":[3,29,46,154],"such":[4],"as":[5,30,78,115],"phenazepam,":[6],"etizolam,":[7],"diclazepam,":[8],"clonazolam":[9],"and":[10,142],"flubromazolam":[11],"have":[12,202],"appeared":[13],"in":[14,47,57,121,124,128,132,136,140,145,158,161,179],"the":[15,36,41,93,97,111,162],"recreational":[16],"drug":[17],"market":[18],"due":[19,186],"to":[20,27,50,55,62,68,169,187],"that":[21,91,99,151],"they":[22,31],"provide":[23],"an":[24,167],"attractive":[25],"alternative":[26],"prescription-only":[28],"are":[32],"readily":[33],"available":[34],"over":[35],"Internet.":[37],"Objective":[38],"To":[39],"describe":[40],"presence":[42],"of":[43,95,189,194,198,207],"new":[44,152,175],"samples":[48,65,73,113],"delivered":[49,67,120],"energy":[51,69,84],"control":[52],"since":[53],"2010":[54,61],"2016":[56],"Barcelona.":[58,180],"Methods":[59],"From":[60,110],"2016,":[63],"24,551":[64],"were":[66,76,81],"control.":[70],"Among":[71],"this":[72],"43":[74,112],"(0.175%)":[75],"analysed":[77],"benzodiazepines.":[79],"They":[80],"analyzed":[82,114],"by":[83,105],"control,":[85],"a":[86,174],"Spanish":[87],"harm":[88],"reduction":[89],"NGO":[90],"offers":[92],"possibility":[94],"analyzing":[96],"substances":[98],"users":[100],"report.":[101],"Analysis":[102],"was":[103,119],"done":[104],"gas":[106],"chromatography-mass":[107],"spectrometry.":[108],"Results":[109],"benzodiazepines,":[116],"1":[117,134],"(2.32%)":[118,135],"2010,":[122],"none":[123],"2011,":[125],"2":[126,130],"(4.65%)":[127,131],"2012,":[129],"2013,":[133],"2014,":[137],"15":[138],"(34.88%)":[139],"2015":[141],"21":[143],"(48.83%)":[144],"2016.":[146],"Discussion":[147],"The":[148,200],"data":[149],"shows":[150],"use":[155],"is":[156],"increasing":[157],"Barcelona,":[159],"especially":[160],"last":[163],"two":[164],"years.":[165],"Abuse":[166],"addiction":[168],"these":[170,195],"drugs":[171],"may":[172,184],"be":[173],"public":[176],"health":[177],"problem":[178],"Unknown":[181],"side":[182],"effects":[183],"appear":[185],"lack":[188],"information":[190],"about":[191],"pharmacokinetic":[192],"profile":[193],"drugs.":[196],"Disclosure":[197],"interest":[199],"authors":[201],"not":[203],"supplied":[204],"their":[205],"declaration":[206],"competing":[208],"interest.":[209]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}